Top

Published in:

01-02-2020 | Systemic Lupus Erythematosus | Editorial

Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases

Author: Hong-Mei Song

Published in: World Journal of Pediatrics | Issue 1/2020

Excerpt

Rheumatic diseases are a group of challenging but fascinating disorders affecting multiple organ systems, and can be trickier in the pediatric population. Much have progressed in this field overtime, as such, the latest knowledge was summarized and presented in this issue, including the basic disease pathogeneses, diagnostic and evaluation tools, and management experiences. …

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed

Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis. 2016;75:481–9.CrossRef

Zou LX, Zhu Y, Sun L, Ma HH, Yang SR, Zeng HS, et al. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00256-0.CrossRefPubMed

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400–12.CrossRef

Zou LX, Lu MP, Jung LKL. Current status and recent advances on the use of ultrasonography in pediatric rheumatic diseases. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00312-9.CrossRefPubMed

Li SC, Zheng RJ. Overview of Juvenile localized scleroderma and its management. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00320-9.CrossRefPubMedPubMedCentral

Barendregt AM, van Gulik EC, Lavini C, Nusman CM, van den Berg JM, Schonenberg-Meinema D, et al. Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents. Eur Radiol. 2017;27:4889–99.CrossRef

Malattia C, Damasio MB, Basso C, Verri A, Magnaguagno F, Viola S, et al. Dynamic contrast-enhanced magnetic resonance imaging in the assessment of disease activity in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49:178–85.CrossRef

McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) clinical characteristics of children recruited within the first 5 year. Rheumatology (Oxford). 2006;45:1255–60.CrossRef

10.

Thyoka M, Adekunle O, Pilkington C, Walters S, Arthurs OJ, Humphries P, et al. Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology (Oxford). 2018;57:1661–8.CrossRef

11.

Eutsler EP, Horton DB, Epelman M, Finkel T, Averill LW. Musculoskeletal MRI findings of juvenile localized scleroderma. Pediatr Radiol. 2017;47:442–9.CrossRef

12.

Neubauer H, Evangelista L, Morbach H, Girschick H, Prelog M, Köstler H, et al. Diffusion-weighted MRI of bone marrow oedema, soft tissue oedema and synovitis in paediatric patients: feasibility and initial experience. Pediatr Rheumatol J. 2012;10:20.CrossRef

13.

Li M, Sauer A, Holl-Wieden A, Pabst T, Neubauer HA. Diagnostic value of diffusion-weighted MRI for imaging synovitis in pediatric patients with inflammatory conditions of the knee joint. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00232-8.CrossRefPubMedPubMedCentral

14.

Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, et al. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein. Rheumatology (Oxford). 2013;52:1467–76.CrossRef

15.

Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3:187–207.CrossRef

16.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92:223–43.CrossRef

17.

Wu JQ, Lu MP, Reed AM. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00313-8.CrossRefPubMedPubMedCentral

18.

Wolstencroft PW, Fiorentino DF. Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies. Curr Rheumatol Rep. 2018;20:28.CrossRef

19.

Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr. Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford). 2010;49:373–81.CrossRef

20.

Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019;78:1722–31.CrossRef

21.

Crow MK, Ronnblom L. Type I interferons in host defence and inflammatory diseases. Lupus Sci Med. 2019;6:e000336.CrossRef

22.

Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2018;392:222–31.CrossRef

23.

Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2019. https://doi.org/10.1007/s12519-019-00229-3.CrossRefPubMed

Title: Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases
Author: Hong-Mei Song
Publication date: 01-02-2020
Publisher: Springer Singapore
Keywords: Systemic Lupus Erythematosus
Juvenile Rheumatoid Arthritis
Juvenile Dermatomyositis
Juvenile Rheumatoid Arthritis
Scleroderma
Interferon
Pediatric Rheumatology
Published in: World Journal of Pediatrics / Issue 1/2020
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI: https://doi.org/10.1007/s12519-020-00340-w

At a glance: The STEP trials

Springer Medicine

Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Current status and recent advances on the use of ultrasonography in pediatric rheumatic diseases

MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis

Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China

Toward a better understanding of type I interferonopathies: a brief summary, update and beyond

Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China

Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment